Bprex Pharma Packaging India Profile
Key Indicators
- Authorised Capital ₹ 72.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 3.15 Cr
as on 17-11-2024
- Company Age 38 Year, 4 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.93 Cr
as on 17-11-2024
- Satisfied Charges ₹ 10.78 Cr
as on 17-11-2024
- Revenue 14.21%
(FY 2023)
- Profit 18.96%
(FY 2023)
- Ebitda 15.25%
(FY 2023)
- Net Worth 19.64%
(FY 2023)
- Total Assets 18.14%
(FY 2023)
About Bprex Pharma Packaging India
The Corporate was formerly known as Rexam Pharma Packaging India Private Limited. The Company is engaged in the Packaging Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 72.00 Cr and a paid-up capital of Rs 3.15 Cr.
The company currently has active open charges totaling ₹2.93 Cr. The company has closed loans amounting to ₹10.78 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jason Greene, Mark Miles, Walid Hamza, and One other member serve as directors at the Company.
- CIN/LLPIN
U24295KA1986PTC060481
- Company No.
060481
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 1986
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Bprex Pharma Packaging India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jason Greene  | Additional Director | 26-Mar-2024 | Current |
| Mark Miles | Additional Director | 26-Mar-2024 | Current |
Walid Hamza  | Additional Director | 26-Mar-2024 | Current |
| Sushant Bhavsar | Additional Director | 16-Jul-2024 | Current |
Financial Performance and Corporate Structure Insights of Bprex Pharma Packaging India.
Bprex Pharma Packaging India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.21% increase. The company also saw a substantial improvement in profitability, with a 18.96% increase in profit. The company's net worth Soared by an impressive increase of 19.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bprex Pharma Packaging India?
In 2023, Bprex Pharma Packaging India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Berry Global India Private LimitedActive 3 years 2 monthsJason Greene, Mark Miles and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Bank Creation Date: 17 Mar 2004 | ₹1.25 M | Open |
Canara Bank Creation Date: 14 Aug 2001 | ₹1.75 Cr | Open |
Canara Bank Creation Date: 04 Jul 2001 | ₹0.70 M | Open |
How Many Employees Work at Bprex Pharma Packaging India?
Bprex Pharma Packaging India has a workforce of 164 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bprex Pharma Packaging India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bprex Pharma Packaging India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
